These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28177223)

  • 1. Facial Layer-by-Layer Engineering of Upconversion Nanoparticles for Gene Delivery: Near-Infrared-Initiated Fluorescence Resonance Energy Transfer Tracking and Overcoming Drug Resistance in Ovarian Cancer.
    Lin M; Gao Y; Diefenbach TJ; Shen JK; Hornicek FJ; Park YI; Xu F; Lu TJ; Amiji M; Duan Z
    ACS Appl Mater Interfaces; 2017 Mar; 9(9):7941-7949. PubMed ID: 28177223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.
    Yang X; Iyer AK; Singh A; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Sci Rep; 2015 Feb; 5():8509. PubMed ID: 25687880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Infrared Light-Triggered Polyprodrug/siRNA Loaded Upconversion Nanoparticles for Multi-Modality Imaging and Synergistic Cancer Therapy.
    Kuang G; Lu H; He S; Xiong H; Yu J; Zhang Q; Huang Y
    Adv Healthc Mater; 2021 Oct; 10(20):e2100938. PubMed ID: 34218522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
    Susa M; Iyer AK; Ryu K; Choy E; Hornicek FJ; Mankin H; Milane L; Amiji MM; Duan Z
    PLoS One; 2010 May; 5(5):e10764. PubMed ID: 20520719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared light triggered photodynamic therapy in combination with gene therapy using upconversion nanoparticles for effective cancer cell killing.
    Wang X; Liu K; Yang G; Cheng L; He L; Liu Y; Li Y; Guo L; Liu Z
    Nanoscale; 2014 Aug; 6(15):9198-205. PubMed ID: 24980695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIR light controlled photorelease of siRNA and its targeted intracellular delivery based on upconversion nanoparticles.
    Yang Y; Liu F; Liu X; Xing B
    Nanoscale; 2013 Jan; 5(1):231-8. PubMed ID: 23154830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].
    Huang R; Yao X; Chen Y; Sun X; Lin Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):108-14. PubMed ID: 27382749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
    Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
    Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-tearable tape close-wrapped upconversion nanocapsules for near-infrared modulated efficient siRNA delivery and therapy.
    Zhang Y; Ren K; Zhang X; Chao Z; Yang Y; Ye D; Dai Z; Liu Y; Ju H
    Biomaterials; 2018 May; 163():55-66. PubMed ID: 29452948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upconversion nanoparticle-based FRET system for study of siRNA in live cells.
    Jiang S; Zhang Y
    Langmuir; 2010 May; 26(9):6689-94. PubMed ID: 20073488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive tracking of hydrogel degradation using upconversion nanoparticles.
    Dong Y; Jin G; Ji C; He R; Lin M; Zhao X; Li A; Lu TJ; Xu F
    Acta Biomater; 2017 Jun; 55():410-419. PubMed ID: 28428038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
    Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
    Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with sequentially peeled upconversion nano-onions.
    He Y; Guo S; Wu L; Chen P; Wang L; Liu Y; Ju H
    Biomaterials; 2019 Dec; 225():119501. PubMed ID: 31561086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional selenium nanoparticles: Chiral selectivity of delivering MDR-siRNA for reversal of multidrug resistance and real-time biofluorescence imaging.
    Chen Q; Yu Q; Liu Y; Bhavsar D; Yang L; Ren X; Sun D; Zheng W; Liu J; Chen LM
    Nanomedicine; 2015 Oct; 11(7):1773-84. PubMed ID: 25959925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA.
    Jiang S; Zhang Y; Lim KM; Sim EK; Ye L
    Nanotechnology; 2009 Apr; 20(15):155101. PubMed ID: 19420539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassay of goat antihuman immunoglobulin G antibody based on luminescence resonance energy transfer between near-infrared responsive NaYF4:Yb, Er upconversion fluorescent nanoparticles and gold nanoparticles.
    Wang M; Hou W; Mi CC; Wang WX; Xu ZR; Teng HH; Mao CB; Xu SK
    Anal Chem; 2009 Nov; 81(21):8783-9. PubMed ID: 19807113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer-Frame-Degradable Nanovehicles Featuring Near-Infrared Dual Luminescence for
    Zheng F; Wang C; Meng T; Zhang Y; Zhang P; Shen Q; Zhang Y; Zhang J; Li J; Min Q; Chen J; Zhu JJ
    ACS Nano; 2019 Nov; 13(11):12577-12590. PubMed ID: 31657911
    [No Abstract]   [Full Text] [Related]  

  • 20. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.